Linezolid

Form: IV Infusion

Strength: 600 mg/300 mL (2 mg/mL)

Reference Brands: Zyvox(US & EU)

Category: Critical Care

Linezolid is an oxazolidinone-class antibiotic used to treat multidrug-resistant Gram-positive infections, including MRSA and VRE. It is available in oral tablets (600 mg), oral suspension (100 mg/5 mL), and IV infusion (600 mg/300 mL), making it versatile for hospital and outpatient settings. In the US, Linezolid is marketed as Zyvox by Pfizer, with generic versions by Fresenius, Teva, and Hikma. In the EU, it is sold as Zyvoxid and through major generics by Sandoz, Mylan, and Accord. Pharma B2B platforms facilitate efficient bulk procurement of Linezolid for hospitals, ICUs, and infectious disease treatment centres.